RATIONALE: The role of serotonin (5-HT) on aggression has been extensively studied; nonetheless, the role of this neurotransmitter in aggression is still inconclusive. OBJECTIVES: The current meta-analytical review investigated the role of increased 5-HT neurotransmission in aggression. METHODS: Preclinical studies using serotonin reuptake inhibitors, 5-hydroxytryptophan, L-tryptophan, or serotonin (5-HT) to increase 5-HT levels were included in this meta-analysis. An overall effect of serotonin on aggression was calculated, and the role of several moderator variables was analyzed. RESULTS: A total of 218 effect sizes revealed that increased 5-HT had an overall significant inhibitory effect on aggression (r = 0.3). The results showed that increased 5-HT had the strongest inhibitory effect on aggression when (1) a specific strain or species (e.g., Long Evans) was used; (2) aggression was offensive or predatory and/or induced by administration of 5,7-dihydroxytryptamine or p-chlorophenylalanine; (3) zimelidine, sertraline, L-tryptophan, citalopram, or 5-HT were used to increase 5-HT; (4) treatment was acute; (5) long chronic treatment durations were used; and (6) time between last injection and behavior testing was within 8 h before or after peak plasma concentration of drug. In contrast, the results revealed that increased-5-HT-facilitated aggression could be predicted when (1) Wistar rats, (2) social isolation or stress to induce aggression, and/or (3) animals treated for less than 3 weeks were used. CONCLUSIONS: Although 5-HT has an overall inhibitory effect on aggression, the animal's genetic background, drug, treatment time, aggression inducing paradigm, and aggression type are critical variables that influence and modify this effect.
RATIONALE: The role of serotonin (5-HT) on aggression has been extensively studied; nonetheless, the role of this neurotransmitter in aggression is still inconclusive. OBJECTIVES: The current meta-analytical review investigated the role of increased 5-HT neurotransmission in aggression. METHODS: Preclinical studies using serotonin reuptake inhibitors, 5-hydroxytryptophan, L-tryptophan, or serotonin (5-HT) to increase 5-HT levels were included in this meta-analysis. An overall effect of serotonin on aggression was calculated, and the role of several moderator variables was analyzed. RESULTS: A total of 218 effect sizes revealed that increased 5-HT had an overall significant inhibitory effect on aggression (r = 0.3). The results showed that increased 5-HT had the strongest inhibitory effect on aggression when (1) a specific strain or species (e.g., Long Evans) was used; (2) aggression was offensive or predatory and/or induced by administration of 5,7-dihydroxytryptamine or p-chlorophenylalanine; (3) zimelidine, sertraline, L-tryptophan, citalopram, or 5-HT were used to increase 5-HT; (4) treatment was acute; (5) long chronic treatment durations were used; and (6) time between last injection and behavior testing was within 8 h before or after peak plasma concentration of drug. In contrast, the results revealed that increased-5-HT-facilitated aggression could be predicted when (1) Wistar rats, (2) social isolation or stress to induce aggression, and/or (3) animals treated for less than 3 weeks were used. CONCLUSIONS: Although 5-HT has an overall inhibitory effect on aggression, the animal's genetic background, drug, treatment time, aggression inducing paradigm, and aggression type are critical variables that influence and modify this effect.
Authors: J M Barreto-Medeiros; E G Feitoza; K Magalhaes; J E Cabral-Filho; F M Manhaes-De-Castro; C M De-Castro; R Manhaes-De-Castro Journal: Nutr Neurosci Date: 2004-02 Impact factor: 4.994
Authors: L C Solberg; N Ahmadiyeh; A E Baum; M H Vitaterna; J S Takahashi; F W Turek; E E Redei Journal: Mol Psychiatry Date: 2003-04 Impact factor: 15.992
Authors: Andrew H Kemp; Tim Outhred; Sasha Saunders; Andre R Brunoni; Pradeep J Nathan; Gin S Malhi Journal: Psychopharmacology (Berl) Date: 2013-12-15 Impact factor: 4.530
Authors: Valentina A Toshchakova; Yalda Bakhtiari; Alexander V Kulikov; Sergey I Gusev; Marina V Trofimova; Olga Yu Fedorenko; Ekaterina V Mikhalitskaya; Nina K Popova; Nikolay A Bokhan; Johannes E Hovens; Anton J M Loonen; Bob Wilffert; Svetlana A Ivanova Journal: Neuropsychobiology Date: 2018-04-05 Impact factor: 2.328
Authors: Florence Thibaut; John M W Bradford; Peer Briken; Flora De La Barra; Frank Häßler; Paul Cosyns Journal: World J Biol Psychiatry Date: 2015-11-23 Impact factor: 4.132
Authors: Carol A Shively; Thomas C Register; J Dee Higley; Stephanie L Willard Journal: Psychopharmacology (Berl) Date: 2013-11-06 Impact factor: 4.530
Authors: Jakob Näslund; Erik Studer; Karin Nilsson; Lars Westberg; Elias Eriksson Journal: Psychopharmacology (Berl) Date: 2013-05-17 Impact factor: 4.530